Description
FUNDING ONLY ACTION
Base award description: HUMAN BLOOD PRODUCTS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-05-27+$100,000= $100,000
- Mod P000012016-09-13+$360,000= $460,000
- Mod P000022019-11-21-$168,391= $291,609
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-05-27 | +$100,000 | $100,000 | HUMAN BLOOD PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2016-09-13 | +$360,000 | $460,000 | FUNDING ONLY ACTION |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-11-21 | −$168,391 | $291,609 | FUNDING ONLY ACTION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F7GBKWAFLM54)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26119N0549 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $200,000 | FY2019 |
| 36C26119N0125 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $289,650 | FY2019 |
| 36C26118N1848 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $250,000 | FY2018 |
| VA26117J1921 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $400,000 | FY2017 |
| VA26216A0088 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA26315P0212 | 437-FARGO VA MEDICAL CENTER · Q999 · MEDICAL- OTHER | $72,571 | FY2015 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26216J0220_3600_VA26216A0088_3600 · retrieved 2026-09-26.